Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rubinstein

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Infectious Agents and Cancer|October 30, 2025
Methylation-specific qPCR for the EBV C promoter to quantify EBV methylationLogan George, Paul G Rubinstein, Jennifer Petr, et al.
Genome Research|November 9, 2017
Nanopore sequencing of complex genomic rearrangements in yeast reveals mechanisms of repeat-mediated double-strand break repairRyan J McGinty, Rachel G Rubinstein, Alexander J Neil, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 22, 2022
Non-invasive, in vivo, characterization of cutaneous metastases using a novel multimodal RCM-OCT imaging device: a case-seriesA S Bang, J Monnier, U Harris, et al.
AIDS (London, England)|December 28, 2017
Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphomaPaul G Rubinstein, Page C Moore, Michelle A Rudek, et al.
Infectious Agents and Cancer|November 15, 2021
Metagenomic analysis to identify novel infectious agents in systemic anaplastic large cell lymphomaParag Mahale, Jason Nomburg, Joo Y Song, et al.
Blood|December 10, 2014
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cellsJonathan Reichel, Amy Chadburn, Paul G Rubinstein, et al.
Neuro-Oncology|September 1, 2016
Long-term survival in AIDS-related primary central nervous system lymphomaNeel K Gupta, Amber Nolan, Antonio Omuro, et al.
Cancer|November 14, 2023
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 StudyLakshmi Rajdev, Chia-Ching Jackie Wang, Himanshu Joshi, et al.
Blood|May 21, 2020
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)Juan C Ramos, Joseph A Sparano, Amy Chadburn, et al.
The Lancet. Haematology|August 2, 2023
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trialPaul G Rubinstein, Page C Moore, Milan Bimali, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Infectious Agents and Cancer|October 30, 2025
Methylation-specific qPCR for the EBV C promoter to quantify EBV methylationLogan George, Paul G Rubinstein, Jennifer Petr, et al.
Genome Research|November 9, 2017
Nanopore sequencing of complex genomic rearrangements in yeast reveals mechanisms of repeat-mediated double-strand break repairRyan J McGinty, Rachel G Rubinstein, Alexander J Neil, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 22, 2022
Non-invasive, in vivo, characterization of cutaneous metastases using a novel multimodal RCM-OCT imaging device: a case-seriesA S Bang, J Monnier, U Harris, et al.
AIDS (London, England)|December 28, 2017
Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphomaPaul G Rubinstein, Page C Moore, Michelle A Rudek, et al.
Infectious Agents and Cancer|November 15, 2021
Metagenomic analysis to identify novel infectious agents in systemic anaplastic large cell lymphomaParag Mahale, Jason Nomburg, Joo Y Song, et al.
Blood|December 10, 2014
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cellsJonathan Reichel, Amy Chadburn, Paul G Rubinstein, et al.
Neuro-Oncology|September 1, 2016
Long-term survival in AIDS-related primary central nervous system lymphomaNeel K Gupta, Amber Nolan, Antonio Omuro, et al.
Cancer|November 14, 2023
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 StudyLakshmi Rajdev, Chia-Ching Jackie Wang, Himanshu Joshi, et al.
Blood|May 21, 2020
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)Juan C Ramos, Joseph A Sparano, Amy Chadburn, et al.
The Lancet. Haematology|August 2, 2023
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trialPaul G Rubinstein, Page C Moore, Milan Bimali, et al.
Pageof 4